sodium phenylbutyrate 3670 MG Granules for Oral Suspension [Olpruva]

RxNorm concept 2626382, branded drug (sbd). Prescribable name: OLPRUVA 3.67 GM Granules for Oral Suspension.

RxCUI: 2626382
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2626382 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

phenylbutyrate 81647

Other names

Olpruva 3.67 GM Granules for Oral Suspension

Related concepts

sodium phenylbutyrate 3670 MG (SCDC, consists of)
sodium phenylbutyrate 3670 MG [Olpruva] (SBDC, consists of)
{1 (sodium phenylbutyrate 3000 MG Granules for Oral Suspension [Olpruva]) / 1 (sodium phenylbutyrate 3670 MG Granules for Oral Suspension [Olpruva]) } Pack [Olpruva 6.67 GM Pack] (BPCK, contained in)
Granules for Oral Suspension (DF, has dose form)
Olpruva (BN, has ingredient)
sodium phenylbutyrate 3670 MG Granules for Oral Suspension (SCD, tradename of)

Linked data

NDCs

72542036701

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2626382 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2626382 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2626382. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.